SEI Investments
IMMX icon

SEI Investments’s Immix Biopharma IMMX Stock Holding History

SEI Investments’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Sell
67,348
-79,792
-54% -$740K ﹤0.01% 2494
2026
Q1 		$1.34M Buy
147,140
+73,570
+100% +$540K ﹤0.01% 2209
2025
Q4 		$385K Buy
+73,570
New +$303K ﹤0.01% 2622

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SEI Investments's IMMX Position: Q2 2026 in Review

SEI Investments reduced its Immix Biopharma (IMMX) stake by 54% in Q2 2026, selling an estimated $740K and leaving 67,348 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

SEI Investments first reported a position in IMMX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.34M in Q1 2026. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • SEI Investments held 67,348 shares of Immix Biopharma worth $694K as of Q2 2026.
  • SEI Investments sold 79,792 Immix Biopharma shares in Q2 2026, an estimated $740K.
  • Immix Biopharma made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2494 holding.
  • SEI Investments first reported a position in Immix Biopharma in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Immix Biopharma position peaked at $1.34M in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.